The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinomaHye Ryun Kim, Byoung Chul Cho, Seungtaek Lim et al.|Annals of Oncology|2013Cited by 125
Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front–Mutant ROS1-Rearranged Non–Small Cell Lung CancerMi Ran Yun, Byoung Chul Cho, Adam J. Schoenfeld et al.|Clinical Cancer Research|2020Cited by 116
Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK RearrangementsYoon Jin, Hyo Sup Shim|PLoS ONE|2014Cited by 75
Dysregulation of TFH-B-TRM lymphocyte cooperation is associated with unfavorable anti-PD-1 responses in EGFR-mutant lung cancerJae-Won Cho, Hye Ryun Kim, Seyeon Park et al.|Nature Communications|2021Cited by 64
Highly Multiplexed Fluorescence in Situ Hybridization for in Situ GenomicsMaristela L. Onozato, A. John Iafrate, Clarence Yapp et al.|Journal of Molecular Diagnostics|2019Cited by 21